Ability of pulmonary function decline to predict death in amyotrophic lateral sclerosis patients

References

• Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, et al. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:194–202.
   PubMed Web of Science ®Google Scholar
• Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology. 1996;47:S71–S81. Discussion S-2.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59:99–103.
   PubMed Web of Science ®Google Scholar
• Fallat RJ, Jewitt B, Bass M, Kamm B, Norris FH Jr. Spirometry in amyotrophic lateral sclerosis. Arch Neurol. 1979;36:74–80.
   PubMed Web of Science ®Google Scholar
• Munsat TL, Andres PL, Finison L, Conlon T, Thibodeau L. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology. 1988;38:409–13.
   PubMed Web of Science ®Google Scholar
• Nakano KK, Bass H, Tyler HR, Carmel RJ. Amyotrophic lateral sclerosis: a study of pulmonary function. Dis Nerv Syst. 1976;37:32–5.
   PubMedGoogle Scholar
• Schiffman PL, Belsh JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration. Chest. 1993;103:508–13.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Zhang H, Shefner JM, Schoenfeld D, Cudkowicz ME, Consortium N. Functional outcome measures as clinical trial endpoints in ALS. Neurology. 2004;63:1933–5.
   PubMed Web of Science ®Google Scholar
• Vender RL, Mauger D, Walsh S, Alam S, Simmons Z. Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival. Amyotroph Lateral Scler. 2007;8:36–41.
   PubMed Web of Science ®Google Scholar
• Clavelou P, Blanquet M, Peyrol F, Ouchchane L, Gerbaud L. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey. J Neurol Sci. 2013;331:126–31.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
   PubMed Web of Science ®Google Scholar
• Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993;43:1316–22.
   PubMed Web of Science ®Google Scholar
• Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000–13.
   PubMed Web of Science ®Google Scholar
• Polkey MI, Lyall RA, Yang K, Johnson E, Leigh PN, Moxham J. Respiratory muscle strength as predictive biomarker for survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2016;195:86–95.
   Web of Science ®Google Scholar
• Terzi N, Corne F, Mouadil A, Lofaso F, Normand H. Mouth and nasal inspiratory pressure: learning effect and reproducibility in healthy adults. Respiration. 2010;80:379–86.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J. 1993;16:1–100.
   Google Scholar
• American Thoracic Society/European Respiratory S. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518–624.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.
   PubMed Web of Science ®Google Scholar
• Sancho J, Servera E, Diaz J, Marin J. Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2007;175:1266–71.
   PubMed Web of Science ®Google Scholar
• Uldry C, Fitting JW. Maximal values of sniff nasal inspiratory pressure in healthy subjects. Thorax. 1995;50:371–5.
   PubMed Web of Science ®Google Scholar
• Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511–22.
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J. 2010;36:12–19.
   PubMed Web of Science ®Google Scholar
• Steier J, Kaul S, Seymour J, Jolley C, Rafferty G, Man W, et al. The value of multiple tests of respiratory muscle strength. Thorax. 2007;62:975–80.
   PubMed Web of Science ®Google Scholar
• Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51.
   PubMed Web of Science ®Google Scholar
• Pupillo E, Messina P, Logroscino G, Beghi E, Group S. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol. 2014;75:287–97.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60:813–19.
   PubMed Web of Science ®Google Scholar
• Bach JR, Bianchi C, Aufiero E. Oximetry and indications for tracheotomy for amyotrophic lateral sclerosis. Chest. 2004;126:1502–7.
   PubMed Web of Science ®Google Scholar
• Similowski T, Attali V, Bensimon G, Salachas F, Mehiri S, Arnulf I, et al. Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. Eur Respir J. 2000;15:332–7.
   PubMed Web of Science ®Google Scholar
• De Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax. 1980;35:603–10.
   PubMed Web of Science ®Google Scholar
• Morgan RK, McNally S, Alexander M, Conroy R, Hardiman O, Costello RW. Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2005;171:269–74.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Corcia P, Lacomblez L, Pochigaeva K, Abitbol JL, Cudkowicz M, et al. Defining survival as an outcome measure in amyotrophic lateral sclerosis. Arch Neurol. 2009;66:758–61.
   PubMed Web of Science ®Google Scholar
• Corcia P, Pradat PF, Salachas F, Bruneteau G, Forestier N, Seilhean D, et al. Causes of death in a post-mortem series of ALS patients. Amyotroph Lateral Scler. 2008;9:59–62.
   PubMed Web of Science ®Google Scholar
• Terzi N, Orlikowski D, Fermanian C, Lejaille M, Falaize L, Louis A, et al. Measuring inspiratory muscle strength in neuromuscular disease: one test or two? Eur Respir J. 2008;31:93–8.
   PubMed Web of Science ®Google Scholar
• Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A. Prognostic factors for the course of functional status of patients with ALS: a systematic review. J Neurol. 2015;262:1407–23.
   PubMed Web of Science ®Google Scholar